VOR
Price:
$0.8
Market Cap:
$54.72M
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
VOR
According to Vor Biopharma Inc.’s latest financial reports and current stock price. The company's current ROE is -86.42%. This represents a change of 284.79% compared to the average of -22.46% of the last 4 quarters.
The mean historical ROE of Vor Biopharma Inc. over the last ten years is -54.08%. The current -86.42% ROE has changed 59.80% with respect to the historical average. Over the past ten years (40 quarters), VOR's ROE was at its highest in in the March 2019 quarter at 30.05%. The ROE was at its lowest in in the March 2020 quarter at -102.74%.
Average
-54.08%
Median
-57.21%
Minimum
-149.83%
Maximum
61.36%
Discovering the peaks and valleys of Vor Biopharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 115.90%
Maximum Annual ROE = 61.36%
Minimum Annual Increase = -344.20%
Minimum Annual ROE = -149.83%
Year | ROE | Change |
---|---|---|
2023 | -78.20% | 115.90% |
2022 | -36.22% | 13.89% |
2021 | -31.80% | -64.58% |
2020 | -89.78% | -40.08% |
2019 | -149.83% | -344.20% |
The current ROE of Vor Biopharma Inc. (VOR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-48.74%
5-year avg
-77.17%
10-year avg
-54.08%
Vor Biopharma Inc.’s ROE is greater than Gracell Biotechnologies Inc. (-37.20%), greater than Theseus Pharmaceuticals, Inc. (-24.51%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Design Therapeutics, Inc. (-18.48%), greater than Erasca, Inc. (-131.94%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Talaris Therapeutics, Inc. (-36.43%), greater than Adicet Bio, Inc. (-63.95%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Nuvalent, Inc. (-28.83%), greater than Ventyx Biosciences, Inc. (-61.43%), greater than Arcellx, Inc. (-12.42%), greater than Kiniksa Pharmaceuticals, Ltd. (-2.08%), greater than Bolt Biotherapeutics, Inc. (-61.40%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Lyra Therapeutics, Inc. (-143.74%), greater than Autolus Therapeutics plc (-66.76%), less than Foghorn Therapeutics Inc. (140.34%), greater than Shattuck Labs, Inc. (-68.65%), greater than Kymera Therapeutics, Inc. (-24.96%), greater than Nurix Therapeutics, Inc. (-63.39%),
Company | ROE | Market cap |
---|---|---|
-37.20% | $989.87M | |
-24.51% | $181.50M | |
-70.40% | $544.07M | |
-18.48% | $300.09M | |
-131.94% | $815.02M | |
-28.01% | $3.24B | |
-36.43% | $116.44M | |
-63.95% | $105.06M | |
-28.37% | $927.05M | |
-28.83% | $6.22B | |
-61.43% | $151.23M | |
-12.42% | $4.69B | |
-2.08% | $1.56B | |
-61.40% | $25.52M | |
-22.40% | $1.50B | |
-143.74% | $16.95M | |
-66.76% | $896.57M | |
140.34% | $454.79M | |
-68.65% | $54.41M | |
-24.96% | $3.08B | |
-63.39% | $1.79B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vor Biopharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vor Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Vor Biopharma Inc.'s ROE?
How is the ROE calculated for Vor Biopharma Inc. (VOR)?
What is the highest ROE for Vor Biopharma Inc. (VOR)?
What is the 3-year average ROE for Vor Biopharma Inc. (VOR)?
What is the 5-year average ROE for Vor Biopharma Inc. (VOR)?
How does the current ROE for Vor Biopharma Inc. (VOR) compare to its historical average?